Supportive therapy following peri-implantitis treatment: A retrospective study on compliance
Metadatos
Mostrar el registro completo del ítemEditorial
Wiley
Materia
Dental implants Peri-Implantitis Periodontal disease
Fecha
2024-03-16Referencia bibliográfica
Monje, A., Galindo-Fernández, P., & Nart, J. (2024). Supportive therapy following peri-implantitis treatment: A retrospective study on compliance. Clinical Oral Implants Research, 00, 1–9. https://doi.org/10.1111/clr.14257
Resumen
Background: The compliance rate with supportive therapy following peri-implantitis
treatment (SPIT) remains unknown. The present retrospective study was carried out
to assess the compliance rate and the factors influencing compliance in a private
practice setting.
Materials and Methods: Patients were divided into three groups according to
compliance rate: regular compliance (RC ≥2 SPIT/year), erratic compliance (EC <2
SPIT/year), and non-compliance
(NC <1 SPIT/year). Overall, 17 patient-(
n = 8) and
site-related
variables (n = 9) were explored as potential confounders of compliance.
The Chi2 test was applied to assess the association between categorical variables and
determine the odds ratio (OR).
Results: The study comprised 159 patients restored with 1075 implants, of which 469
were treated for peri-implantitis
and met the inclusion criteria. A total of 57.2% were
RC, 25.8% EC, and 17% NC. The multivariate analysis showed that smoking and grade
C periodontitis reduced the likelihood of RC (OR = 0.28, p < .001) when compared to
complete edentulism or non-smoking.
Moreover, age demonstrated being associated
with follow-up
when SPIT was interrupted in EC and NC (OR = 0.94, p = .007).
Conclusion: Comprehensive information, provided prior to peri-implantitis
treatment,
regarding the importance of adhering to SPIT after peri-implantitis
treatment to
achieve/maintain peri-implant
health, resulted in ~60% regular compliance rate
(NCT05772078).